Hanna Rahbek Mortensen

MD, clinical associate professor The Danish Centre for Particle Therapy, Aarhus University Hospital hanna.mortensen@auh.rm.dk
Research interests

DK: Engageret i forskning indenfor strålebehandling af kræft i spiserør, mavemund og mavesæk, lever og galdeveje samt lymfomer.

UK: Engaged in research within radiotherapy of cancer in the gullet, cardia and stomach, liver and gallbladder, and lymphoma. 

 Workgroups Publications
  • Møller DS, Poulsen PR, Hagner A, Dufour M, Nordsmark M, Nyeng TB, Mortensen HR, Lutz CM, Hoffmann L Strategies for Motion Robust Proton Therapy With Pencil Beam Scanning for Esophageal Cancer Int J Radiat Oncol Biol Phys . 2021 Oct 1;111(2):539-548 2021
  • Worm ES, Hansen R, Høyer M, Weber B, Mortensen H, Poulsen PR Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations Phys Med Biol . 2021 Oct 12;66(20) 2021
  • Mortensen HR, Høyer M, Grau C. Proton therapy Ugeskr Laeger. 2019 Oct 14;181(20A). 2019
  • Shamshad M, Møller DS, Mortensen HR, Ehmsen ML, Jensen MF, Hoffmann L Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer Acta Oncol . 2022 Jul 1;1-10 2022
  • Hoffmann L, Mortensen H, Shamshad M, Berbee M, Bizzocchi N, Bütof R, Canters R, Defraene G, Ehmsen ML, Fiorini F, Haustermans K, Hulley R, Korevaar EW, Clarke M, Makocki S, Muijs CT, Murray L, Nicholas O, Nordsmark M, Radhakrishna G, Thomas M, Troost EGC, Vilches-Freixas G, Visser S, Weber DC, Møller DS Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres Radiother Oncol . 2022 Jul;172:32-41 2022
  • Mortensen HR, Villadsen GE, Worm ES, Weber B Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience Scand J Gastroenterol. 2021 Mar;56(3):259-265 2021
  • Thuehøj AU, Andersen NC, Worm ES, Høyer M, Tabaksblat EM, Weber B, Mortensen HR Clinical outcomes after stereotactic ablative radiotherapy in locally advanced cholangiocarcinoma Acta Oncol. 2022 Feb;61(2):197-201 2022